At Northshore–Edward Elmhurst Health, all patients are offered genetic testing as part of their primary care visit. This helps clinicians create more personalized care plans and facilitates earlier disease diagnoses, said Kristen Murtos, the health system's chief innovation and transformation officer.
As the industry moves towards more personalized medicine, pharmacogenomics could play a key role in keeping patients healthier longer and in getting them viable treatments for their unique genetic profile.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Nest Genomics just closed a $8.5 million seed financing round. The company provides the software infrastructure needed for health systems, clinics, drugmakers and payers to launch and scale genomic programs. It also provides tools for patients to easily access their genetic information.
Drugs that work for one patient may not work for another, even if both patients have the same diagnosis. This is why each patient should be tested to select the most effective and least toxic drug regimen for that individual before initiating treatment.
Genetic tests are becoming available for a wider range of applications. During a CB Insights panel discussion, Phil Febbo of Illumina and Alicia Zhou of Color explained what they think needs to happen to make these tests accessible and affordable for more people.
Telehealth startup Genome Medical recently raised $60 million in funding led by Casdin Capital. It’s using part of the funds to acquire GeneMatters, which would add more genetic counselors to its staff.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The Illinois-based health system is teaming up with the analytics company to launch a genomics program, which will focus on predicting the risk of illness and outcomes among patients. It will also provide free genetic testing to low-income patients in an effort to increase access to genomic care.
The future of precision medicine will come only as quickly as doctors can pick out clinically useful information from the genetic data being gathered on their patients.
In the last 20 years, access to genetic testing has expanded significant as technology has advanced. But there’s still lots of work to be done to get tests covered and make them more accessible, panelists said at a virtual conference hosted by MedCity News.
On the company's LunaDNA platform, a whole genome can be exchanged for 300 company shares, while 20 days of fitness data is equal to two shares.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
As part of the partnership, select participants in the Healthy Nevada Project can get counseling and other genetic services from Genome Medical.
Helix is responsible for sequencing the user's DNA and passing results to PerkinElmer, which will provide data analysis and interpretative services using the company's team of medical geneticists.
Genetic testing, particularly to determine risk or early detection of cancer, is becoming more prevalent and available yet, in economic terms, supply outstrips demand.
As part of a new initiative called DNA10K, more than 10,000 NorthShore patients will gain access to Color's clinical-grade genetic testing and whole genome sequencing.
Collaboration will leverage genetic testing company's data resources and pharma companies drug-development expertise.